[Adverse events of inhaled steroids in childhood]

C Marguet1, L Couderc, M Lubrano

  • 1Unité de pneumologie et allergologie pédiatrique, hôpital Charles-Nicolle, CHU, 76031 Rouen cedex, France. christophe.marguet@chu-rouen.fr

Insights

Inhaled corticosteroids are preferred over oral steroids for children. While short-term effects are minimal, long-term impacts on growth and bone health are less concerning with newer medications, though monitoring is advised.

Area of Science:

  • Pediatric Endocrinology
  • Pharmacology
  • Respiratory Medicine

Context:

  • Pediatricians express concern regarding inhaled corticosteroid (ICS) adverse events on growth and bone mineralization.
  • Differentiating short, intermediate, and long-term effects is crucial for accurate risk assessment.

Purpose:

  • To review current data on the adverse effects of inhaled corticosteroids (ICS) in children.
  • To provide evidence-based recommendations for pediatricians regarding ICS use and monitoring.

Summary:

  • Inhaled corticosteroids are preferable to oral steroids due to fewer systemic adverse events.
  • Recent data suggest newer ICS formulations have minimal long-term impact on adult height and bone mineralization.
  • Practitioners must be aware of recommendations to minimize ICS adverse events, including monitoring growth and addressing local effects like cough.

Impact:

  • Informed clinical practice regarding ICS use in pediatric asthma and other respiratory conditions.
  • Improved patient outcomes through optimized therapeutic strategies and reduced adverse event incidence.
  • Highlights the need for continued research into long-term ICS effects and optimal monitoring protocols.

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: β2-Adrenoceptor Agonists01:25

Antiasthma Drugs: β2-Adrenoceptor Agonists

Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...